Bayesian Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Bayesian Capital Management's IONS Position: Q3 2026 in Review
Bayesian Capital Management opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2026: 9,200 shares worth $411K. The stake represents 0.33% of the portfolio and ranks #87 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in IONS as recently as Q3 2025.
Bayesian Capital Management first reported a position in IONS in Q4 2016 and has held it in 9 quarters since. The position peaked at $1.62M in Q3 2025. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Bayesian Capital Management held 9,200 shares of Ionis Pharmaceuticals worth $411K as of Q3 2026.
- Ionis Pharmaceuticals was a new Bayesian Capital Management position in Q3 2026.
- Ionis Pharmaceuticals made up 0.33% of Bayesian Capital Management's portfolio in Q3 2026, its #87 holding.
- Bayesian Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2016 and has held it in 9 quarters since.
- Bayesian Capital Management's Ionis Pharmaceuticals position peaked at $1.62M in Q3 2025.
- 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Bayesian Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.